Alleviation of osteoarthritis progression through far-infrared therapy targeting osteoclast cytoskeleton and MAPK/c-Fos/NFATc1 signaling inhibition. - Qin B; Lu HA; Xu XF; Yang JJ; Wang YP; Zhang HT; Fu SJ; Qu YQ; Wu WY; Zheng WY; Xu YL; Sit CL; et al. (Pharmacological research, 2026)